Abstract
Biomarkers may be helpful in prediction of outcomes of infants with congenital diaphragmatic hernia. The predictive value of high-sensitivity troponin T and N-terminal pro-brain natriuretic peptide was investigated in 128 infants with congenital diaphragmatic hernia. After correction for multiple testing, those biomarkers did not predict severe pulmonary hypertension, death, need of extracorporeal membrane oxygenation, or bronchopulmonary dysplasia. Trial registration Netherlands Trial Registry: 1310.
Original language | English |
---|---|
Pages (from-to) | 245-249.e4 |
Journal | Journal of Pediatrics |
Volume | 173 |
DOIs | |
Publication status | Published - Jun 2016 |
Bibliographical note
Funding Information:Supported by Stichting Sophia Wetenschappelijk Onderzoek and the Willem H. Kröger Foundation (549) . The authors declare no conflicts of interest.
Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.